 | • レポートコード：MRC2203A735 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界の羊水穿刺針市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（100〜150mm、150mm以上、100mm以下）分析、処置別（羊水穿刺、羊水除去の、胎児輸血、羊水注入、臍帯穿刺）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の羊水穿刺針市場規模：種類別（100〜150mm、150mm以上、100mm以下） ・世界の羊水穿刺針市場規模：処置別（羊水穿刺、羊水除去の、胎児輸血、羊水注入、臍帯穿刺） ・世界の羊水穿刺針市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（The Ccoper Companis Inc.、Becton, Dickinson and Company、Cook Medical Incorporated、...） ・市場機会・将来の傾向 |
The market for amniocentesis is expected to grow steadily over the forecast period. Certain factors that are responsible for the growth of this market are the growing median age of first-time motherhood, the increasing burden of the congenital diseases, and the high reliability of people on amniocentesis.
Amniocentesis is almost 99.4% accurate and this test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward’s syndrome, Tay-Sachs disease, Huntington’s disease, sickle cell disease, and cystic fibrosis. It can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, its adoption is good across several healthcare facilities, therefore the market is expected to expand over the forecast period.
Key Market Trends
Amniocentesis Procedure is Expected to Show Steady Growth Over the Forecast Period
Rising concern about genetic disorders is the major factor responsible for the growing number of procedures. Various studies have been conducted by organizations such as the National Institute of Health (NIH) to understand the risks associated with amniocentesis procedure and the challenges during the same. Studies have revealed that the occurrence of early abortion after amniocentesis is a major risk and its prevalence is around 10%. However, the technical advancements in the needles, and the focus of medical professionals on the safety of the patient, it is expected that the instances of early abortions will be reduced in the near future. Furthermore, the increasing birth rate globally is enhancing market growth. India is the leading country in terms of having the highest birthrate.
Therefore, due to the increasing birth rate, rising number of amniocentesis procedures, growing adoption of the same, and increasing focus on patient safety, the amniocentesis procedure segment is expected to show steady growth over the forecast period.
North America to Maintain Lead in the Amniocentesis Market
The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market over the forecast period. Factors, such as the rising government initiatives and an increasing number of amniocentesis procedures, are driving the growth of the market in this region.
The developed healthcare system in the United States is augmenting the demand for advanced products which is accelerating the growth of amniocentesis needles with advanced technology. Added to that, a concern of the general population in the North America region about the genetic disorders in a newborn is propelling the demand for amniocentesis procedure.
Competitive Landscape
The market for amniocentesis needles is moderately competitive and is comprised mostly of local companies. Countries like China and India are having a large number of local suppliers for the amniocentesis needles which is posing an intense competition among these local companies. The market is also witnessing the presence of global companies but the competition among the big players is comparatively lower than that of the local players.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Reliability of Amniocentesis
4.2.2 Growing Median Age of First-Time Motherhood
4.2.3 Increasing Burden of Congenital Disorders
4.3 Market Restraints
4.3.1 Availability of Alternate Methods
4.3.2 Lack of Skilled Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 100 to 150 mm Needles
5.1.2 Larger Than 150 mm Needles
5.1.3 Smaller Than 100 mm Needles
5.2 By Procedure
5.2.1 Amniocentesis Procedures
5.2.2 Amnioreduction Procedures
5.2.3 Fetal Blood Transfusion Procedures
5.2.4 Amnioinfusion Procedures
5.2.5 Cordocentesis Procedures
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 The Ccoper Companis Inc.
6.1.2 Becton, Dickinson and Company
6.1.3 Cook Medical Incorporated
6.1.4 RI.MOS. Srl
6.1.5 Smiths Medical
6.1.6 Laboratoire Ccd
6.1.7 Integra Lifesciences
6.1.8 Medtronic Plc
6.1.9 Medline Industries Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS